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Abstract
The ever-broadening scope of phage research has left behind the simplistic view 
of studying phages as just model systems in phage biology to a much broader appli-
cation ranging from ecological management to immunity. Improved throughput 
technology in crystallography and structural studies has helped our understanding 
of these systems as supramolecular machines that possess the capacity of self-
assembly. The idea of phages as self-assembling supramolecular nano-machines that 
are bioactive biomaterials in characteristics, tunable and easily producible have lent 
its utility to recent fields such as regenerative medicine and tissue engineering. Due 
to low metabolic activity and slow nutrient diffusion within cartilage, damage to 
this tissue often inevitably consist of slow and delayed regeneration and healing, the 
restriction of blood from reaching most part of this tissue and the resultant limita-
tions in the availability of oxygen and other essential amino acids dictates a very 
slow systemic metabolic response also since transports system in this tissue have to 
employ less speedy forms. Cartilage regeneration therefore is a huge challenge. This 
chapter takes a look at the application of the phage display technology in cartilage 
tissue regeneration.
Keywords: self-assembling, supramolecular, bioactive biomaterials, cartilage tissue 
regeneration, phage display
1. Introduction
In nature, there exist remarkable structural complexities created out of self-
assembly, for instance ice crystals from falling snow. In Molecular self-assembly, 
molecules adopt specific arrangement automatically without the direction of 
outside source. Phages like liquid crystals behave in such similar fashion, having the 
ability to self-assembly. Phages are viruses that infect bacterial cells, and also serve 
as most commercial vectors for recombinant DNA studies. Molecular self-assembly 
is a key concept in phage chemistry. The components of most phages or viruses in 
general have an assembly system which usually is directed through non-covalent 
interactions such as hydrogen bonding, hydrophobic forces, van der Waals forces, 
and electrostatic etc., leading to the formation of supramolecular assemblies 
composed of different shapes and sizes [1]. For instance, the interaction of the 
P22 phage tailspike protein with its capsid to form an infective phage is entirely 
non-covalent, however, once interaction is complete, bond reversibility is impos-
sible [2]. Molecular self-assembly allows the construction of interesting molecular 
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topologies. This self-assembly system is also crucial in biological systems in the 
form of the formation of biomolecular condensates in living organisms, also found 
in oligomerization of protein subunits to form multimers of complex structures 
[3]. The application of this system therefore is a bottom-up approach, in which 
components of the phages are directed to self-assembly to achieve a programmed 
molecular topology, consisting of the desired shape and functional groups.
Most researches have delved into self-assembling filamentous phages, thus shed 
light on the pathways for their self-assembly. Filamentous bacteriophages such as 
the Escherichia coli K12-infecting Ff phages (F1, Fd or M13) replicate episomally 
and contain a circular single-stranded DNA packaged into long filaments. These 
phages are secreted into the environment without lysing their host. The knowledge 
of phages in general and filamentous phages in particular can played such a vital 
role in formulating new approaches in fabricating bioactive biomaterials [4] and 
providing for synergies and opportunities in phage display and tissue engineering 
approaches.
2.  Phage as biotechnological platform for cartilage study, therapy  
and diagnosis
Due to a low metabolic activity and slow nutrient diffusion within cartilage, 
damage to this tissue often inevitably consist of slow and delayed regeneration 
and healing, the restriction of blood from reaching most part of this tissue and 
the resultant limitations in the availability of oxygen and other essential amino 
acids dictates a very slow systemic metabolic response since transports system in 
this tissue have to employ less speedy forms such as transport proteins across  
the thick ECM. Accidents that cause injury to the knee may sometimes rupture the 
articular cartilage. Most diseases associated with articular cartilage include the 
following; 1) osteoarthritis; a condition where the cartilage covering the bones 
in joints is thinned and sometimes completely worn out. This leads to exposure 
of the bone ends to friction and erosion which causes bone damage. Aberrant 
immunometabolism has also been implicated in most phenotypes of osteoar-
thritis [5]. 2) Rheumatoid arthritis is a chronic systemic autoimmune disease 
that primarily affects the lining of the synovial joints. This disease is progressive 
with the pathological mechanism driven via the deterioration of cartilage, bone 
erosion; hyperplastic synovium and systemic consequences [6]. Most symptoms 
of rheumatoid arthritis include arthralgia, swelling, redness, joint pain and hence 
limiting the range of motion [7]. 3) Some other disease/conditions related to 
cartilage degeneration are relapsing polychondritis [8, 9], achondroplasia [10], 
costochondritis [11, 12], herniation [13], chondrosarcoma [14], chondroma [15] 
etc. While biological factors have been well known to play crucial roles in the eti-
ology of these diseases, therapeutic management of these conditions have proved 
less reliable. Below, we discuss some related works that have been done in the cell-
phage research interface, and how the knowledge of both fields could synchronize 
to help find answers for cartilage regeneration and therapy challenges.
2.1 Using phage to regulate alignment and morphology of chondrocytes
Chondrocytes in articular cartilage have unique alignment with respect to the 
articular surface, this is crucial for the functional performance of the cartilage. A 
deeper comprehension of the chondrocytes and collagen alignment is important 
for a better appreciation of the load bearing and shock absorption function of this 
tissue. Chondrocytes are organized into four zonal layers in the articular cartilage 
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tissue: superficial zone, middle zone, deep zone and calcified zone. The superficial 
zone contains elongated and flattened chondrocytes whereas the middle zone has 
rounded chondrocytes as shown in Figure 1. The deep zone and calcified zone have 
hypertrophic chondrocytes. Cartilage tissue has one of the poorest proliferative 
capacities and loss of chondrocytes as well as abrasions to the articular surface 
could give rise to osteoarthritis [16–18]. In cartilage regenerative effort, the interest 
usually is to produce cartilage with high performance comparable to the natural tis-
sue, and this implies supplying chondrocytes with the right physical and molecular 
cues to direct their proliferation, differentiation and tissue regeneration. Therefore, 
guiding the topological and structural organization of the scaffold in which chon-
drocytes are seeded as well as modulating the molecular cues functionalized to the 
scaffold is of crucial importance for cartilage tissue regeneration.
In a biomimetic strategy, He and his colleagues synthesized nanofibrous bio-
inorganic hybrid materials by using phage as a model biological nanofiber and 
calcium hydroxyapatite (HAP) as a model inorganic material [19]. They induced the 
nanofibers self-assembly into phage-cation complex structures through electrostatic 
interaction between anionic phage nanofibers and the free precursor cations of the 
inorganic materials. Successful orientation of collagen molecules was also reported. 
This bioengineered phage bio-nanofibers as biotemplates oriented the nucleation 
of HAP, formed cluster of structures induced by calcium ions. They observed that 
the orientations of HAP crystals were formed along Ca2+ induced phage bundles, 
then finally, their co-assembled collagen-phage hybrid bundles induced an aligned 
nucleation of HAP on them [19].
This gives an excellent platform for cartilage tissue regeneration experiments 
since collagen fibers arrangement and alignment is a critical measure of cartilage 
performance. In articular cartilage, the superficial zone consists of mostly type I 
collagens that are aligned parallel to the articular surface to reduce friction. Hence, 
the use of such a novel framework for collagen orientation in cartilage regenerative 
effort will prove useful. The ability to determine the assembly and orientation of 
collagen or minerals by this co-assembly process in a bio-mimetic scaffold presents 
Figure 1. 
Cartoon illustration of the anatomical structure of the articular cartilage, depicting the collagen fibers 
orientation and chondrocytes morphology. The superficial zone consists of flattened and horizontally aligned 
chondrocytes with also horizontally aligned collagen fibers, predominantly collagen I. the transition zone has 
rounded chondrocytes, with randomly aligned collagen II fibers; the deep zone has vertically aligned columns of 
chondrocytes with vertical collagen alignment.
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an interesting process for producing excellent cartilage or bone tissue via tinkering 
the organization and orientation of both proteins and HAP in order to produce 
superior functional and mechanical properties of cartilage or bone tissue [20].
Young and his colleagues demonstrated that phage-based array chips could 
be used for an optically readable cell proliferation and morphology assays. They 
engineered M13 phages that that displayed RGD on its major coat proteins and also 
functionalized the growth factor, FGF2, on its minor coat proteins. Since M13 can 
self-assembly, they constructed from them a nanofibrous network scaffold, then 
grew cells on them. They monitored for biochemical cues displayed by the phage 
on cell proliferation and morphology. This elegant work allowed for the utility of 
engineered phages for sensitive monitoring of the effects of functional peptides on 
cell growth [21].
2.2  Phage used for chondrogenic differentiation of stem cells for cartilage 
engineering
The chondrogenic potential of mesenchymal stem cells (MSCs) allows for stem 
cell therapy of damaged cartilage possible. These stem cells can easily be obtained 
via biopsy from the patient then amplified in the laboratory. This has therefore 
made MSCs a routinely used cell types for cartilage regeneration [22, 23].
Phage display derived functional peptides has been employed for chondrogenic 
differentiation of MSCs [24].
TGF-β1- and collagen II-binding peptides were identified through phage 
display biopanning by Meng and his colleagues [25]. They discovered the peptide 
HSNGLPL to have high affinity to TGF-β1 receptor, the peptide was then func-
tionalizedbypolyurethane with side propynyl groups via CuAAC click reaction to 
form nanofiber gel materials with high TGF-β1-binding affinity which acted as 
an absorbent for TGF-β1 within gels [24, 25]. Their findings demonstrated that 
their construct induced chondrogenic differentiation of human MSCs in vitro and 
promoted rabbit articular cartilage regeneration.
2.3 Using phage display to initiate cellular signaling
Integrins are transmembrane receptors for extracellular matrix proteins [26]; 
they play a crucial role in signal transduction in chondrocytes and control cellular 
attachment, migration, proliferation and apoptosis etc. One of the severally known 
signaling pathways initiated by integrinsare the Src pathway, this pathway is known 
to coordinate very vital cellular processes [27], downstream of which include the 
RHO, SMAD, AKT etc. as depicted in Figure 2. While the RHO pathway transduced 
via integrins acts to regulates actin cytoskeleton [28] leading to cell spread and 
migration, the AKT through ERK pathway is crucial for chondrocytes growth, 
proliferation and survival [27, 28]. Interestingly also, downstream of Src, upon ERK 
pathway activation, the transcription factor SMAD1/5/8 is known to be blocked 
from nuclear translocation, thereby blocking chondrocyte’s hypertrophy, and bone 
formation processes [29–31]. This step is crucial for forming normal cartilage. 
While the SMAD signaling pathway will eventually lead to the inhibition of chon-
drocyte’s hypertrophy, the RHO signaling improves cells motility and migration, 
whereas, the ERK pathway could signal chondrocytic differentiation of MSCs into 
chondrocytes for cartilage regeneration.
To influence chondrocytic differentiation of MSCs for cartilage regeneration 
therefore, as diagrammatically illustrated in Figure 2, integrin binding peptides 
such as RGD, IKVAV or DGEA can be genetically engineered to display on the 
surface of the coat protein of the phage. The displayed peptides which have high 
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affinity for integrin receptor will interact with integrin on the plasma membrane of 
the stem cells. This will allow for direct activation of the integrin receptors by the 
displayed peptide. The process of activating integrin receptor occurs in sequential 
conformational changes. First, the extracellular subunits of integrin initiate several 
conformational changes leading to a more opened and sensitive state from the 
previously closed and insensitive state, the sensitive state allows for bond formation 
between the peptide and the receptor. Upon binding to the phage displayed peptide, 
the integrin receptor activates cascades of signaling including the SMAD, AKT, and 
RHO signaling pathways which could signal chondrocytic differentiation of MSCs 
into chondrocytes for cartilage regeneration.
2.4  Bio-responsive materials with optimal mechanical and degradation 
characteristics
The development of scaffolds for cartilage tissue regeneration must include 
mechanical properties since loading conditions have substantial effect on this 
tissue. Hence, the optimal mechanical properties of scaffold for cartilage regenera-
tion usually are expected to produce better cartilage tissue formation that must 
suit the functional role of load bearing. For this reason, it is imperative to carefully 
regulate the mechanical as well as the degradation properties of the scaffolds used 
Figure 2. 
Diagrammatic illustration of the possible mechanisms of phage displayed peptide on integrin mediated 
signaling pathway. Integrin binding peptide such as RGD, IKVAV or DGEA can be genetically engineered 
to display on the surface of the coat protein of the phage. The displayed peptide which have high affinity for 
integrin receptor will interact with integrin on the plasma membrane, the extracellular subunits of integrin 
then initiates several conformational changes leading to a more opened and sensitive state from the previously 
closed and insensitive state, enabling the bound formation between the peptide (ligand) and the receptor. 
Upon binding to the phage displayed peptide, the integrin receptor activates cascades of signaling including 
the SMAD, ERK, RHO signaling pathways via signal transduction. While the SMAD signaling pathway 
will eventually lead to the inhibition of chondrocyte’s hypertrophy, the RHO signaling improves cells motility 
and migration, whereas, the ERK pathway could signal chondrocytic differentiation of prechondrocytes into 
chondrocytes for cartilage regeneration.
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in cartilage engineering. In an ideal case, the biomaterial should eventually be 
remodeled and replaced by the chondrocytes and the chondrocytes’ secreted ECM 
and studies along these lines have been conducted [32, 33]. The development and 
application of ‘smart’ bioresponsive materials that can respond to biological cues or 
to pathological abnormalities are of great interest to both researchers and clinicians, 
and this is more so important especially in the case of cartilage tissue regeneration 
and osteoarthritis therapy in which precise administration of therapeutics with 
minimal invasiveness is key. A good review on this topic is covered by Yu and his 
colleagues [33].
In a related study, osteogenic differentiation of mouse preosteoblasts induced 
by collagen-derived DGEA-peptide on nanofibrous phage tissue matrices was 
carried out by Yoo and his colleagues [34]. They constructed genetically engineered 
M13 phage with DGEA-peptide displayed in high density on the major coat proteins 
and studied the effects of the DGEA-peptides on preosteoblast morphologies. 
Their results demonstrated that preosteoblasts grown on DGEA-incorporated 
phage matrices exhibited significant outgrown morphology with early bone cell 
marker protein expression. In the cartilage tissue, since it is nonvascular, cell to 
cell communication is slow and most signaling is via ECM embedded proteins, 
physical cues, peptides, etc. in the tissue extracellular matrices and such play 
vital role in controlling chondrocyte’s growth, proliferation, and ECM molecules 
deposition and remodeling of cartilage ECM. A replicate study in which the 
peptide KRTGQYKL is displayed on M13 and prechondogenic cells are grown on 
such matrices will be of interesting discovery since this peptide is known to induce 
chondrogenesis [35].
2.5  Assessment of normal cartilage and degenerative cartilage using phage 
display derived functional peptides
The cartilage is an avascular tissue that expresses high levels of hyaluoronic 
acid (HA) via the hyaluoronic acid synthase. Classic histochemical analysis of HA 
are usually performed using Alcian blue or using the HA-specific probe, known 
as HA-binding protein (HABP), however since HABP is a complex of aggrecans 
and link proteinsderived from bovine cartilage, published data seems to indicate 
discrepancies [36]. Zymolik and Mummert via phage display identified a novel HA 
binding peptide for which they coined pep-1 which demonstrated excellent stain-
ing for dermis, however, they recorded sensitivity of pep-1 conformation changes 
in HA [22]. The pep-1 peptide therefore could serve as HA expression probe for in 
situ detection of hyaluronans since normal cartilage tissue formation is governed by 
high expression levels of HA, hence assessment of cartilage tissue could be probed 
via pep-1 too.
The activation of hyaluronan synthase leads to the production and deposi-
tion of HA on the ECM of the cartilage for repair and remodeling. It has been 
shown to modulate inflammation and fibroplasia during wound repair. Tolg et al. 
using phage display identified another peptide, P15-1 (STMMSRSHKTRSHHV), 
by biopanning through 7-to 15mer phage display libraries. This 15mer peptide 
showed similarity to the receptor for hyaluronan mediated motility (RHAMM) 
binding sequences, and was demonstrated to show high affinity to HA and keenly 
mimicked the functional properties of RHAMN. In an in vivo experiment, P15-1 
significantly reduced wound macrophage number, fibroblast number, and blood 
vessel density compared to negative control peptides in rat wounds and promoted 
scarless wound healing. They showed that P15-1 blocks RHAMM-regulated focal 
adhesion kinase pathways in fibroblasts and attenuated fibrotic repair by blocking 
hyaluronan oligosaccharide signaling [37]. Since the avascular articular cartilage 
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must deal with frictional forces, scar formation is unwanted; therefore the ability 
to ensure scarless healing is of paramount importance.
Another important molecule of the characteristically thick ECM of cartilage 
tissue is decorin. It is known to bind to aggrecan to increase its adhesion with other 
aggrecan molecules and with collagen II fibrils, thereby enhancing the assembly and 
structural integrity of the aggrecan network in cartilage ECM. At the cellular level, 
decorin functions to increase the retention of aggrecan in the newly formed matrix 
of chondrocytes. Also, this molecule increases the adhesion between aggrecan and 
aggrecan molecules and between aggrecan molecules and collagen II fibrils [38]. 
It has been shown to inhibit TGF-β and hence prevent tissue fibrosis and promote 
tissue regeneration. Jarvinen and Ruoslahti genetically displayed a wound-homing 
CAR peptide (CARSKNKDC) on the decorin surface to form a recombinant CAR-
decorin. After intravenous injection of CAR-decorin, these complexes selectively 
accumulated in the wound sites, and promoted wound healing, without scar forma-
tion in a mice wound model [39], this displayed peptide therefore can be employed 
for cartilage wound healing process, since osteoarthritis is characterized by a persis-
tent deterioration of the cartilage tissue or basically and an non-healing wound.
2.6 Phage used for targeted cartilage tissue drug delivery
By phage biopanning, Pi and his colleagues discovered the chondrocyte-homing 
peptide, DWRVIIPPRPSA (CAP). They also chemically conjugated the peptide 
with polyethyleneimine (PEI) to construct a non-viral gene vector [40]. The CAP-
functionalized PEI vectors showed specificity for cartilage tissue and gene trans-
fection efficiency in the knee joints was demonstrated to be excellent, and can be 
employed for cartilage therapy. In another study, they employed the same construct 
to deliver siRNA into the cartilage of the knee joints to silence the expression of 
Hif-2α [41]. Hif-2α, which is one of the molecules that triggers cartilage degradation 
in osteoarthritis (OA), was therefore downregulated and cartilage degeneration 
and synovium inflammation in the knee joints were alleviated. In both cases, they 
showed that the use of the cartilage specific and chondrocyte-homing peptide 
identified by phage display could make therapy of degenerate cartilage feasible.
2.7 Using phage display for diagnosis and imaging
The development of osteoarthritis or rheumatoid arthritis is noted to be highly 
linked with MMP13 expression, a collagenase that degrades collagen and biglycans 
[42, 43]. Sun-Jun and his colleagues’ utilized phage display to map out the substrate 
specificity of this enzyme, their screening revealed that MMP13 targeted with 
specificity to peptide substrates that have proline at the P3 position and lipophilic 
amino acids at P1′. They observed that a change in proline via site-directed muta-
genesis made these substrates less sensitive to collagenase 3 [44]. Integrins are 
transmembrane heterodimeric proteins that play a role as mechanotransducers; 
they also mediate a number of other signaling cascades and triggers endocytosis 
[45] and or pinocytosis [46] that mediate cellular internalization. Chondrocytes 
plasma membranes have surface integrins subunits [47]. A fluorophore that is 
therefore bound to a ligand that interacts with integrins can be internalized. Hart 
and his coworkers demonstrated using bacteriophage Fd that displayed the cyclic 
integrin-binding peptide sequence GGCRGDMFGC on the major coat protein 
subunits. This led to the internalization of the phage by cells, thus demonstrating 
that the integrin-binding peptides displayed on the phage could target cells expres-
sion integrin on its surface for internalization [48], and this could be exploited 
to have the phage coat protein also functionalized to a fluorophore that serve for 
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immunofluorescent imaging. Same process can also be exploited for the possible 
introduction of siRNA or preloaded drugs into cells for therapy.
2.8 Deploring CRISPR with phage technology for cartilage regeneration
CRISPR technology has proven to be a highly efficient and specific target 
genome editing technology for eukaryotes; and has been demonstrated as an excel-
lent technology for specific genes silencing, genes knockouts, or knockdowns appli-
cations. Therefore this technology can be employed to silence specific gene products 
in cartilage tissues that amplify the deterioration of cartilage during rheumatoid 
arthritis or osteoarthritis. For instance, high MMP13 [49, 50], RUNX2 [51], VEGF 
[52] etc. expressions in cartilage tissue usually are pointers to cartilage degeneration 
and abnormality [53] and hence can be silenced through this CRISPR technology. 
The bottleneck remains nonetheless on homing CRISPR to cartilage tissue. Shefah 
and his team showed that P22 phage served as a robust supramolecular protein cage 
that could be utilized for cell type-specific delivery of encapsulated cargos [54]. 
They genetically fused Cas9 to a truncated form of the P22 phage scaffold protein, 
thereby packaging Cas9 and a single-guide RNA (sgRNA) inside the P22 capsid. 
Since the sgRNA is tunable, specifying which gene to target therefore is achievable. 
Homing such a delivery vehicle to cartilage tissue can be achieved via molecular 
engineering process. The chondrocyte-homing peptide, DWRVIIPPRPSA as 
discovered by Pi and his colleagues [40] could be chemically functionalized to 
the engineered P22 phage capsid construct (P22-Cas9: sgRNA complex) using 
polyethyleneimine. On the other hand, a genetic engineering approach in which the 
P22 phage tailspike protein is tinkered to contain this chondrocyte homing peptide 
(DWRVIIPPRPSA) especially at the C-terminus can then be assembled onto the P22 
phage capsid construct encapsulating the Cas9-sgRNA. The P22 tailspike protein is 
well known for its tolerance to several physiological and environmental conditions 
such as protease, heat and detergents [55]. It is biocompatible and posse no harm to 
the human body. The non-covalent but irreversible binding of the phage’s tailspike 
to its capsid will lead to the production of a phage construct with capsid loaded 
with the right gene regulatory factor(s) that has the capacity for cartilage specific 
targeting.
2.9 Using phage to develop biosensors for cartilage wound progression
Cartilage defect in knee such as in the case of rheumatoid arthritis or osteo-
arthritis or even in the event of joint injury can lead to matrix metalloproteinase 
expression enhancement and degenerative events [42, 43, 56, 57]. Inflammation is 
also known to be associated with joint symptoms and progression of osteoarthritis. 
The molecular markers of inflammation can be assessed in joint fluids and tis-
sues from patients [58] using phage display technology. Phage based biosensors 
can be employed to sense the degeneration and extent of wound and even early 
detection of the degenerative event. These biosensors could reflect the effects of 
medical treatment. For instance, phage library can be screened against the MMP13 
upregulation in osteoarthritis to select highly selective and affinity-binding phages 
to MMP13. Similar studies as done by Sun-Jun and his colleagues’ as mentioned 
earlier utilized phage display to map out specificity to MMP13 [44]. These selec-
tive phages can detect MMP13 in the injured or degenerative joints and thus can be 
employed for sensor designs and constructs. Several phage-based biosensors have 
been constructed for detection of pathogens, antigens, secreted proteins in various 
disease states [59–61]. For instance, Singh and Amit used immobilized engineered 
tail spike proteins derived from the P22 bacteriophage onto gold surfaces using 
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thiol-chemistry to analytical detect Salmonella with the sensitivity of 103 CFU/mL 
[62]. This technique has also been employed to successfully detect E. coli O157:H7, 
methicillin-resistant S. aureus [63], S. aureus [64], and hepatitis B virus [65]. 
Similarly, landscape phage has been successfully used as a molecular recognition 
interface to detect Bacillus anthracic spores [66], Salmonella [62, 67] and even in the 
detection of prostate serum antigen [68].
3. Conclusions
Even though there exist copious discoveries on the genetic factors as well as the 
molecular mechanisms surrounding cartilage degeneration, the efficacious treat-
ment modalities remain elusive. Phage display provides an advantageous platform 
to study, diagnose and treat cartilage related diseases, since this provide a nano scale 
molecular mechanism that have the benefits of possessing higher tissue penetra-
tion, high specificities to cartilage, tunable, and hence can be leveraged for cartilage 
therapy, diagnoses, imaging and research application. By far, majority of phages 
used for display are biocompatible, and hence can serve as ideal drug delivery 
systems with minimal to no side effects to the human body upon administration, 
and should attain tremendous efficacy. The ability to fine tune drug loaded phages 
by functionalizing homing peptides to the phage particle offer a special pharma-
cokinetic characteristic, since it provides for regulated and targeted distribution 
of the payload, and ensure safety. Nonetheless, the use of phages for cartilage 
therapy still remains an obscured subject, and many obstacles should necessarily be 
surmounted. First, the choice of the right phage display libraries through phage bio-
panning is a critical step that will ensure the generation of the right ligand peptides 
for display. Secondly, there must be a concerted effort to direct cartilage studies to 
understand more cartilage targeting peptides and the specific genetic and molecular 
mechanisms that should be reversed in degenerated cartilage therapy process. The 
specific receptor target moieties, chondrocyte-ECM dynamic relationships, the 
biology of cartilage tissue ECM remodeling and ECM molecules secretion, deposi-
tion and recycling must all be understood in vivo to ensure enhanced application of 
phage technology for human cartilage regeneration.
Abbreviations
AKT Ak strain transforming
CFU Colony forming unit.
CRISPR clustered regularly interspaced short palindromic repeats.
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ERK extracellular-signal-regulated kinase.
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HABP hyaluoronic acid binding protein.
HAP hydroxyapatite.
Hif-2α Hypoxia Inducible Factor-2 alpha.
MMPs matrix metalloproteinases.
MSCs Mesenchymal stem cells.
PEI polyethyleneimine.
RHAMM receptor for hyaluronan mediated motility.
RHO Ras homologous.
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